Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination. - Wikidata - awgldk - TriplyDB

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.

http://www.wikidata.org/entity/Q37574913

about

Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study.Direct renin inhibition improves parasympathetic function in diabetes Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease.Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?Aldosterone blockade in chronic kidney disease: can it improve outcome?Resistant hypertension in the high-risk metabolic patient.Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.

P2860

Q35184945-38DC191B-8421-403E-88ED-6E4BF558BEFF Q36472703-20BE10EA-FB6F-4F0E-B010-9981198180E3 Q36548207-CB4454E6-FC85-4D84-88EF-9730AAFF2A87 Q36701736-9D952795-BBFD-4D4F-B6B0-DFBC7C65F383 Q37656354-61F8DCE7-5EB9-4CBA-B0E2-C4E33A4F065D Q37772047-A6F5D764-BFC7-46FB-BC17-CFF0907E8CF8 Q37799756-4603FBEE-96D6-49A1-9EC4-9D20F13D3484 Q37976974-5D64D286-3DF8-4683-8BFB-EA855E498FEE

P2860

Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.

http://www.wikidata.org/entity/Q37574913

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dual blockade of the renin-ang ...... receptor blocker combination.

@en

Dual blockade of the renin-ang ...... receptor blocker combination.

@nl

type

label

Dual blockade of the renin-ang ...... receptor blocker combination.

@en

Dual blockade of the renin-ang ...... receptor blocker combination.

@nl

prefLabel

Dual blockade of the renin-ang ...... receptor blocker combination.

@en

Dual blockade of the renin-ang ...... receptor blocker combination.

@nl

P1433

Q37574913-906DC2C9-71A6-40E1-9A2E-66F79F1A2CD4

P1476

Q37574913-5742C5FD-9143-4BAB-98E6-69FABCE971CF

P2093

Q37574913-5D1F2741-08CF-4FA1-B638-B55149321F85

Q37574913-651DE6DE-8D21-43A5-B47A-4E4F739A86E6

P2860

Q37574913-02750303-28C5-40A8-952E-5D0D68F1BCF9

Q37574913-0423AB79-717A-433C-8068-7F23F1B0A97F

Q37574913-0B038E09-D3B9-4137-A64F-58FF7DF22100

Q37574913-161EC049-51F9-4A99-8F63-779687C2E42D

Q37574913-19BD0EC7-8CD7-42A2-B1C7-CCFD0DEFA0BA

Q37574913-1B7339A0-4DDF-434B-BD4E-7AA2CCEE98DE

Q37574913-1C4D5F68-630B-410E-A4A4-5FAF5BFF2116

Q37574913-25782475-BAD4-4751-A9B6-76FFC1D62472

Q37574913-25A35DB2-63BB-4ECE-81B6-2686D60749D9

Q37574913-29DA6CE4-E91F-4E52-B3B2-205E4EE126F0

P304

Q37574913-A2C0137E-AB5A-47F0-9240-10748F11EE3A

P31

Q37574913-4CC82677-078D-4C9F-86B5-64101FB69ECB

P356

Q37574913-99F4734F-A0CE-4A94-8935-0107DEC56D57

P433

Q37574913-A9129EAE-1B86-45C5-B813-822409A7DDE7

P478

Q37574913-DA93B7EC-CC04-49A9-9EF6-39CFDEE864FA

P577

Q37574913-D0886FBB-A75E-4712-A13E-1C084195CAE6

P698

Q37574913-13DDA4C3-49B0-4480-AEDA-B8F1BC412122

P356

P1433

American Journal of Hypertension

P1476

Dual blockade of the renin-ang ...... receptor blocker combination.

@en

P2093

Andrew S Bomback

http://www.w3.org/2001/XMLSchema#string

Robert Toto

http://www.w3.org/2001/XMLSchema#string

P2860

Supramaximal dose of candesartan in proteinuric renal disease

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Structure-based design of aliskiren, a novel orally effective renin inhibitor

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

Aliskiren: the first renin inhibitor for clinical treatment

Renin inhibition: what are the therapeutic opportunities?

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

P304

1032-1040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJH.2009.138

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19661925

http://www.w3.org/2001/XMLSchema#string